Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04639583
Other study ID # 20-382
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2021
Est. completion date June 30, 2023

Study information

Verified date May 2024
Source University of New Mexico
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Near-infrared spectroscopy (NIRS), is a technology that can provide continuous, non-invasive monitoring of oxygenation in tissue. The objective of this study is to obtain the cerebral regional oxygen saturation (cRSO2) in a preterm population that is born at altitude to determine if the range of "normal" values is different than those obtained at sea level.


Recruitment information / eligibility

Status Completed
Enrollment 21
Est. completion date June 30, 2023
Est. primary completion date June 30, 2023
Accepts healthy volunteers No
Gender All
Age group 0 Hours to 24 Hours
Eligibility Inclusion Criteria: - Infant must be <32 weeks' gestational age at time of delivery. - Consenting mother/guardian of the infant must speak English. Other languages are not being included due to the need of a translator being brought into the unit, which adds risk to the vulnerable population. Additionally, as the time to consent is a narrow window, adding the complexity of getting a translator may delay the ability to get consent and thus make it more difficult to enroll patients. - Infants that require blood transfusions during the monitoring time may be included. Exclusion Criteria: - Any known cardiac anomaly or other anomaly which may impair perfusion and blood flow. - Infant born after placental abruption or concern for extreme blood loss immediately after birth. - Unable to consent the mother/guardian due to maternal health issues after delivering (eg requiring intubation or sedation after the delivery). - Mothers/guardians that are prisoners, as the study team would like to have continuing communication with the mother during the study period as needed. - Mothers/guardians that are <18 years of age will not be approached for consent. - Any mother/guardian that is not able to consent due to having a legal representative will not be approached for consent in this study. - Any infant that is planned to be placed for adoption - Infant is greater than 24 hours of age at time of consent.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Near-infrared spectroscopy (NIRS) utilization
The NIRS devise will be applied so that cerebral regional oxygen saturation (cRSO2) can be measured.

Locations

Country Name City State
United States University of New Mexico Albuquerque New Mexico

Sponsors (1)

Lead Sponsor Collaborator
University of New Mexico

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cerebral Regional Oxygen Saturation (cRSO2) Measure cRSO2 for the first 96 hours of life in infants born preterm. first 96 hours of life
Secondary Incidence of Major Complications of Prematurity Additional items recorded to determine if there is any correlation with the cRSO2 values, including death, intraventricular hemorrhage, necrotizing enterocolitis, sepsis, duration of supplemental oxygen required, time to taking full volume feeds via nippling, and hospital length of stay. From birth until the end of the birth hospitalization, which would be discharge home or death, whichever occurs first. Estimated time is up to 6 months of age.
See also
  Status Clinical Trial Phase
Completed NCT03641209 - Extremely Low Gestatonal Age Infants' Paracetamol Study Phase 1/Phase 2
Recruiting NCT04114435 - Pulmonary Vascular Disease and Cardiac Performance in Extreme Preterm Infants
Recruiting NCT04294368 - Targeted Fortification of Donor Breast Milk in Preterm Infants N/A
Completed NCT03504215 - Exercise Intervention to Rescue the Adverse Effect of Preterm Birth on Cardiovascular and Pulmonary Health. N/A
Recruiting NCT05615311 - Respiratory Outcomes After Early Vitamin D Supplementation in Infants Born Extremely Preterm Phase 1/Phase 2
Recruiting NCT04735315 - Assessment of Renal Function in Adults Born Preterm: The HAPI-Kidney Study
Completed NCT05684419 - Preterm Infants Born to Homeless Mothers.
Recruiting NCT04270240 - A NEW SCORING SYSTEM FOR PREDICTION OF PDA
Completed NCT04535375 - Sonographic QUantification of Venous Circulation In the Preterm Brain N/A
Recruiting NCT05280340 - Anakinra for Preterm Infants Pilot Phase 1/Phase 2
Recruiting NCT05827250 - Vibroacoustic Study of Lung Development in Newborn Infants
Recruiting NCT05824377 - To Determine the Best Feeding Practice in Preterm Infants on Non-invasive Ventilation. N/A
Completed NCT03635944 - Nutritional Care and Head Growth in Preterm Infants
Completed NCT03261609 - Risk of Chronic Diseases in Young Adults Born Preterm: Relationship With Inflammation and Oxidative Stress Biomarkers.
Active, not recruiting NCT04325308 - Early Protein Supplementation in Extremely Preterm Infants Fed Human Milk N/A
Active, not recruiting NCT04545866 - The Budesonide in Babies (BiB) Trial Phase 3